[HTML][HTML] A comprehensive review of the protein subunit vaccines against COVID-19
Two years after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), in
December 2019, the first infections were identified in Wuhan city of China. SARS-CoV-2 …
December 2019, the first infections were identified in Wuhan city of China. SARS-CoV-2 …
[HTML][HTML] Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world
In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …
[HTML][HTML] Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia
Background: Pfizer-BioNTech and Oxford-AstraZeneca are recently introduced vaccines to
combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have been …
combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have been …
Gold-nanostar-chitosan-mediated delivery of SARS-CoV-2 DNA vaccine for respiratory mucosal immunization: development and proof-of-principle
The COVID-19 pandemic is caused by the coronavirus SARS-CoV-2 (SC2). A variety of anti-
SC2 vaccines have been approved for human applications, including those using …
SC2 vaccines have been approved for human applications, including those using …
[HTML][HTML] mRNA-based vaccine for COVID-19: they are new but not unknown!
mRNA vaccines take advantage of the mechanism that our cells use to produce proteins.
Our cells produce proteins based on the knowledge contained in our DNA; each gene …
Our cells produce proteins based on the knowledge contained in our DNA; each gene …
Acute inflammatory diseases of the central nervous system after SARS-CoV-2 vaccination
AG Francis, K Elhadd, V Camera… - Neurology …, 2022 - AAN Enterprises
Background and Objectives Acute inflammatory CNS diseases include neuromyelitis optica
spectrum disorders (NMOSDs) and myelin oligodendrocyte glycoprotein antibody …
spectrum disorders (NMOSDs) and myelin oligodendrocyte glycoprotein antibody …
[HTML][HTML] Ocular manifestations after receiving COVID-19 vaccine: a systematic review
YK Lee, YH Huang - Vaccines, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has had profound and lasting
consequences since 2019. Although vaccines against COVID-19 have been developed and …
consequences since 2019. Although vaccines against COVID-19 have been developed and …
[HTML][HTML] COVID-19 vaccines and thrombosis—roadblock or dead-end street?
Two adenovirus-based vaccines, ChAdOx1 nCoV-19 and Ad26. COV2. S, and two mRNA-
based vaccines, BNT162b2 and mRNA. 1273, have been approved by the European …
based vaccines, BNT162b2 and mRNA. 1273, have been approved by the European …
[HTML][HTML] The inclusive review on SARS-CoV-2 biology, epidemiology, diagnosis, and potential management options
A novel coronavirus member was reported in Wuhan City, Hubei Province, China, at the end
of the year 2019. Initially, the infection spread locally, affecting the Wuhan people, and then …
of the year 2019. Initially, the infection spread locally, affecting the Wuhan people, and then …
RETRACTED: Safety and immunogenicity of a recombinant receptor‐binding domain‐based protein subunit vaccine (Noora vaccine™) against COVID‐19 in adults: A …
The development of a safe and effective vaccine is essential to protect populations against
coronavirus disease 2019 (COVID‐19). There are several vaccine candidates under …
coronavirus disease 2019 (COVID‐19). There are several vaccine candidates under …